Dedicated #GIST researchers led by superhero Dr. Michael Heinrich. Basic & Clinical GIST research performed at @OHSUKnight & @VAresearch. #sarcoma#slayGIST
#newtotwitter We are the Heinrich Lab! We are a small but mighty group. We study #GIST, aiming to understand the molecular mechanisms of disease to provide better diagnostic tools and treatment strategies for patients. #SlayGIST
My PhD work from the @GistLab is now published! This study provides paradigm-shifting evidence that not all exon 18 PDGFRA mutant GIST require avapritinib treatment, and instead could be treated with imatinib based on mutation status - a win for those unable to access avapritinib
Presented at ASCO, new data from the Phase 1/1b StrateGIST-1 trial demonstrated that velzatinib (IDRX-42) is highly active & tolerable as both a first-line and later-line therapy across a wide spectrum of KIT mutations in advanced #GIST.
#ASCO26@ASCO#clinicaltrials#velzatinib
Thank you to @GistLab of @OHSUKnight for participating in an interview to unpack a ctDNA analysis of the phase 1/1b StrateGIST 1 trial. Check out highlights from the interview on https://t.co/E5LOd0oiTe #oncology#ASCO26@asco
The recordings from the GIST Summit 2025/GDOL Texas cohosted by GIST Support International, the LRG & @MDAndersonNews are now available: https://t.co/DPkk0s73Gr or go directly to our YouTube channel @LiferaftgroupOrg #GISTeducation#GISTSummit#GDOL#ThrivingTogether
GIST Summit 2025/GDOL Texas hosted by GIST Support International & the LRG & MD Anderson is March 1 at 8am in Houston. Details & Registration: https://t.co/SodMQ1ovlF
Thank you @ctosociety for allowing me to present my work again this year. I'm so honored to receive the best GIST poster award! Thank you to Dr. Heinrich @GistLab for your mentorship and to our awesome collaborators like @seppobauer and @Liferaftgroup!
@OHSUKnight#CTOS2024
And also co-authors on (P177) PREDICTING THE IMATINIB RESPONSE OF PDGFRA EXON 18-MUTANT GASTROINTESTINAL STROMAL TUMOR USING IN VITRO MODELS https://t.co/yol6jqSdxd
@HKhosroyani@GistLab@OHSUKnight#imatinib#collaboration
Fantastic turnout and engagement
@OHSUKnight GIST Education Day.
Really enjoyed connecting with everyone,
hearing about the latest clinical trials and
discussing the multidisciplinary, individualized
approach to this rare disease with @GistLab
Kicking off the #GISTTSummit2024 in Essen organized by @seppobauer & Jonathan Fletcher, with presentations by #GIST experts Ping Chi, Michael Heinrich @GistLab, and John Glod. Looking forward to 3 days filled with scientific exchange centered around GIST! #Sarcoma
Congratulations to all, and thank you for your dedication, commitment to excellence, and compassion on behalf of the GIST community! #LifeFest#ThrivingTogether#dedication
#ShareYourColors On #RareDiseaseDay! Today and every day, we invite all rare patients & caregivers to share their story. Let’s make awareness for rare diseases less rare! #GISTHOPE
So honored to have received the award for best GIST poster @ctosociety !!! Thank you to Dr. Heinrich for your mentorship and to all those that stopped by yesterday during the poster reception. @GistLab@OHSUKnight#ctos2023#slayGIST